Argenx
ARGX
#638
Rank
$31.87 B
Marketcap
$533.00
Share price
-0.62%
Change (1 day)
3.69%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : $0.53 B

According to Argenx 's latest financial reports the company's total liabilities are $0.53 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Argenx - Total liabilities on balance sheet (from 2021 to 2020)

Total liabilities by year

Year Total liabilities Change
2022-12-31$0.32 B1.43%
2021-12-31$0.31 B-57.29%
2020-12-31$0.73 B53.33%
2019-12-31$0.48 B819.27%
2018-12-31$52.49 M40.4%
2017-12-31$37.39 M-20.27%
2016-12-31$46.9 M352.51%
2015-12-31$10.36 M-16.92%
2014-12-31$12.47 M97.69%
2013-12-31$6.31 M-23.95%
2012-12-31$8.29 M58.05%
2011-12-31$5.24 M95.03%
2010-12-31$2.69 M